Human Health Secures €4.7M to Revolutionize Patient-First Precision Healthcare with AI and Data-Driven Insights
November 1, 2025
The funding will support expanding Human Health’s UK operations, developing the Precision Health OS, and scaling research partnerships via its B2B platform, Human Evidence.
Users can capture medical history, monitor interventions, and generate clinician-ready reports, with optional de-identified data contributing to research; the platform uses AI to surface patterns across mind, body, and lifestyle.
The system combines patient-reported data with AI to create a feedback loop that helps individuals track health, identify patterns, and produce actionable insights for clinicians.
LocalGlobe, a London-based VC, led the seed round and typically backs early-stage healthtech and fintech startups.
Participation in the round included LocalGlobe, Airtree Ventures, Skip Capital, and angels Arvind Rajan, Eric Salama, and David Shein.
A Australia- and London-based patient-first precision health platform, Human Health, secured a seed round of 4.7 million euros in October 2025, led by LocalGlobe with participation from Airtree Ventures, Skip Capital, Aliavia, Scale Ventures, and angel investors including Arvind Rajan, Eric Salama, and David Shein.
The funding round was announced to accelerate development of the Precision Health OS, broaden condition coverage, and enable patients to contribute anonymised data to research, while expanding the company’s UK operations.
The company plans to scale its B2B offering, Human Evidence, to allow life sciences partners to collect real-world, patient-reported data at scale.
When clinical visits are needed, the platform compiles a clear report from real patient data to assist clinicians.
Human Health aims to broaden access to personalised healthcare by expanding its footprint and capabilities.
Airtree Ventures, a Sydney-based VC, backs technology startups in Australia and New Zealand, with emphasis on software/SaaS, fintech, and enterprise tech.
Headquartered in Australia, the company seeks to make personalised healthcare accessible to everyone.
The founders, Kate Lambridis and Georgia Vidler, built an operating system for patient-led precision healthcare to unify health data, track patterns, and generate doctor-ready insights.
Skip Capital is a multi-asset private investment fund investing in technology startups from seed to growth.
Summary based on 2 sources
Get a daily email with more Startups stories
Sources

Tech.eu • Oct 30, 2025
Human Health secured €4.7M to expand its patient-first Precision Health
The SaaS News • Oct 31, 2025
Human Health Raises £4.1M Seed Round | The SaaS News